Literature DB >> 17200281

Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.

Matthew Knight1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17200281     DOI： 10.1542/peds.2006-2467

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  3 in total

1.  Sudden unexplained cardiac arrest in apparently healthy children: a single-center experience.

Authors:  Srilatha Alapati; Nathaniel Strobel; Sharukh Hashmi; John T Bricker; Monesha Gupta-Malhotra
Journal:  Pediatr Cardiol       Date:  2012-10-04       Impact factor: 1.655

Review 2.  Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder.

Authors:  Gary Stiefel; Frank M C Besag
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

Review 3.  Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Authors:  Jose Martinez-Raga; Carlos Knecht; Nestor Szerman; María I Martinez
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.